Hesperidin may successfully enhance superoxide dismutase (SOD) and catalase (CAT) levels in bronchoalveolar lavage fluid (BLAF) while decreasing IL-6, malondialdehyde (MDA), and IL-8 in BLAF and the lung MPO content in COPD mice. This evidence concerns the gene CAT and chronic obstructive pulmonary disease.